Orchard Therapeutics

Developer of gene therapies for treating rare diseases

placeLondon, England, United Kingdom calendar_todayFounded 2015 groups117 employees language orchard-tx.com

Registered entities

Social engagement

Social engagement: 55.5K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

32 investors on record; lead investors include Baillie Gifford, F-Prime Capital, ORI Capital, Deerfield; 2 have since exited.

Investor typeCountShare
Venture capital1547%
Angel & family office13%
Bank & private debt39%
Other / undisclosed1341%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

1 May 2026 · Senior Medical Science Liaison - Gene Therapy US Medical Affairs · Boston

24 Feb 2026 · Medical Science Liaison - Gene Therapy US Medical Affairs

13 Sep 2025 · Executive Director, Regulatory Science · Boston

26 Jan 2025 · Therapeutic Operations Lead - Benelux · Leiden

Based on job postings tracked across public sources.

Recent activity

28 Aug 2025
Event
iciem2025
Coming soon